CONMED Statistics

Share Statistics

CONMED has 30.95M shares outstanding. The number of shares has increased by 0.36% in one year.

Shares Outstanding	30.95M
Shares Change (YoY)	0.36%
Shares Change (QoQ)	0.1%
Owned by Institutions (%)	99.99%
Shares Floating	30.16M
Failed to Deliver (FTD) Shares	972
FTD / Avg. Volume	0.22%

Short Selling Information

The latest short interest is 2.11M, so 6.83% of the outstanding shares have been sold short.

Short Interest	2.11M
Short % of Shares Out	6.83%
Short % of Float	9.46%
Short Ratio (days to cover)	5.49

Valuation Ratios

The PE ratio is 15.94 and the forward PE ratio is 11.42. CONMED's PEG ratio is 0.15.

PE Ratio	15.94
Forward PE	11.42
PS Ratio	1.62
Forward PS	1.1
PB Ratio	2.19
P/FCF Ratio	13.72
PEG Ratio	0.15

Financial Ratio History

Enterprise Valuation

CONMED has an Enterprise Value (EV) of 2.99B.

EV / Sales	2.29
EV / EBITDA	10.99
EV / EBIT	17.92
EV / FCF	19.45

Financial Position

The company has a current ratio of 2.3, with a Debt / Equity ratio of 0.94.

Current Ratio	2.3
Quick Ratio	1.05
Debt / Equity	0.94
Debt / EBITDA	3.33
Debt / FCF	5.89
Interest Coverage	5.37

Financial Efficiency

Return on Equity is 13.76% and Return on Invested Capital is 8.02%.

Return on Equity	13.76%
Return on Assets	5.74%
Return on Invested Capital	8.02%
Revenue Per Employee	$335.13K
Profits Per Employee	$33.95K
Employee Count	3,900
Asset Turnover	0.57
Inventory Turnover	1.66

Taxes

Income Tax	30.61M
Effective Tax Rate	18.77%

Stock Price Statistics

The stock price has increased by -20.53% in the last 52 weeks. The beta is 1.17, so CONMED's price volatility has been higher than the market average.

Beta	1.17
52-Week Price Change	-20.53%
50-Day Moving Average	52.82
200-Day Moving Average	61.28
Relative Strength Index (RSI)	59.92
Average Volume (20 Days)	443,109

Income Statement

In the last 12 months, CONMED had revenue of 1.31B and earned 132.42M in profits. Earnings per share was 4.29.

Revenue	1.31B
Gross Profit	733.03M
Operating Income	200.33M
Net Income	132.42M
EBITDA	272.18M
EBIT	200.33M
Earnings Per Share (EPS)	4.29

Full Income Statement

Balance Sheet

The company has 24.46M in cash and 905.78M in debt, giving a net cash position of -881.32M.

Cash & Cash Equivalents	24.46M
Total Debt	905.78M
Net Cash	-881.32M
Retained Earnings	560.28M
Total Assets	2.33B
Working Capital	362.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 166.97M and capital expenditures -13.08M, giving a free cash flow of 153.88M.

Operating Cash Flow	166.97M
Capital Expenditures	-13.08M
Free Cash Flow	153.88M
FCF Per Share	4.99

Full Cash Flow Statement

Margins

Gross margin is 56.08%, with operating and profit margins of 15.33% and 10.13%.

Gross Margin	56.08%
Operating Margin	15.33%
Pretax Margin	12.47%
Profit Margin	10.13%
EBITDA Margin	20.82%
EBIT Margin	15.33%
FCF Margin	11.77%

Dividends & Yields

CNMD pays an annual dividend of $1, which amounts to a dividend yield of 1.46%.

Dividend Per Share	$1.00
Dividend Yield	1.46%
Dividend Growth (YoY)	0%
Payout Ratio	28.25%
Earnings Yield	6.27%
FCF Yield	7.29%

Dividend Details

Analyst Forecast

The average price target for CNMD is $57.5, which is 9.6% higher than the current price. The consensus rating is "Hold".

Price Target	$57.5
Price Target Difference	9.6%
Analyst Consensus	Hold
Analyst Count	5

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$107.25
Lynch Upside	104.36%
Graham Number	54.91
Graham Upside	4.63%

Stock Splits

The last stock split was on Sep 10, 2001. It was a forward split with a ratio of 3:2.

Last Split Date	Sep 10, 2001
Split Type	forward
Split Ratio	3:2

Scores

Altman Z-Score	2.1
Piotroski F-Score	7

CONMED Corporation (CNMD)